Evidence map›Paper›PMID 10642298›Full record

ArticleHypertension (Dallas, Tex. : 1979)2000

Angiotensin I-converting enzyme antisense gene therapy causes permanent antihypertensive effects in the SHR.

H Wang, P Y Reaves, M L Gardon, K Keene, D S Goldberg, C H Gelband, M J Katovich, M K Raizada

RetractedAbstract readRetracted Publication
PubMed Publisher
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. The role of the nervous system in hypertension.Current hypertension reports · 2001
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

H WangDepartment of Physiology, College of Medicine, University of Florida, and the University of Florida Brain Institute, Gainesville, FL 32610-0274, USA.
P Y Reaves
M L Gardon
K Keene
D S Goldberg
C H Gelband
M J Katovich
M K Raizada
Florida College · US

Funding

CVD protection mechanisms involving ACE2/Ang-(1-7) axisR01HL056921 · NHLBI · UNIVERSITY OF FLORIDA · PI RAIZADA, MOHAN K. · 1996 to 2015
$9.2M
REGULATION OF RENAL VASCULAR CELLS IN HYPERTENSIONR01HL052189 · NHLBI · UNIVERSITY OF FLORIDA · PI GELBAND, CRAIG H · 2000 to 2001
$537k
REGULATION OF RENAL VASCULAR CELLS IN HYPERTENSIONR29HL052189 · NHLBI · UNIVERSITY OF FLORIDA · PI GELBAND, CRAIG H · 1996 to 1999
–
NHLBI NIH HHS HL-52189NHLBI NIH HHS HL-56921
6 · The paper itself

Abstract

The renin-angiotensin system plays a critical role in the control of blood pressure (BP), and its hyperactivity is associated with the development and maintenance of hypertension. Although traditional pharmacological therapies targeted toward the inhibition of the renin-angiotensin system are effective in the control of this disease, they pose significant limitations. We used an antisense gene delivery strategy to circumvent these limitations and established that a single intracardiac administration of angiotensin type 1 receptor antisense (AT(1)R-AS) causes permanent prevention of hypertension in the spontaneously hypertensive rat (SHR), an animal model of primary human hypertension. Our objectives in this study were 2-fold: to determine (1) whether the targeting of angiotensin I-converting enzyme (ACE) mRNA by a similar antisense strategy would prevent the SHR from developing hypertension and (2) whether the antihypertensive phenotype is transmitted to the offspring from the antisense-treated parents. Administration of a retroviral vector containing ACE antisense (LNSV-ACE-AS) caused a modest yet significant attenuation of high BP ( approximately 15+/-2 mm Hg) exclusively in the SHR. This was associated with a complete prevention of cardiac and renovascular pathophysiological alterations that are characteristic of hypertension. Like their parents, the F(1) generation offspring of the LNSV-ACE-AS-treated SHR expressed lower BP, decreased cardiac hypertrophy, and normalization of renal arterial excitation-coupling compared with offspring derived from the LNSV-ACE-tS (truncated sense)-treated SHR. In addition, the endothelial dysfunction commonly observed in the SHR renal arterioles was significantly prevented in both parents and offspring of the LNSV-ACE-AS-treated SHR. Polymerase chain reaction followed by Southern analysis revealed that the ACE-AS was integrated into the SHR genome and transmitted to the offspring. These observations suggest that transmission of ACE-AS by retroviral vector may be responsible for the transference of normotensive phenotypes in the SHR offspring.

Indexed as

Genetic TherapyAcetylcholineAngiotensinsAnimalsBlood PressureBradykininCardiomegalyCell LineCoronary CirculationDose-Response Relationship, DrugFemaleGene Expression Regulation, EnzymologicHypertensionMaleOligonucleotides, AntisensePeptidyl-Dipeptidase AAcetylcholineAngiotensinsBradykininOligonucleotides, AntisensePeptidyl-Dipeptidase APhenylephrineVasodilator Agents

Identifiers

PMID10642298
OpenAlexW2080162113

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.